Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The "new" management is already ousted, will they still RS?
Recent form 8-k filings show that Alon Natason quit.
On July 28, 2013, Alon Natanson, Chief Executive Officer of Brainstorm Cell Therapeutics Inc. (the "Company"), informed the Company of his resignation from his position with the Company effective 90 days after such notice."
If anyone remembers it was his job to accelerate the process to Nasdaq which included the R/S.
I am going to go out on a limb here, but I speculate we might not see an RS now that he's gone.
This had some good info it in...
Was happy to hear the CEO talking about the STOCK not just the technology. He seemed pretty confident about them being fast tracked. I hope we see some renewed attention when/if they get the US FDA trial underway.
Fantastic!
Let's hope we see a press release on this from BCLI.
Nathanson: "The FDA has allowed us to enter a Phase IIb U.S. on the basis of the results of the Israeli experiment. Comes to the trial of 50 patients, and we hope to start, and maybe even finish it this year."
Midas,
this info was from the article you posted - If accurate FDA has approved Phase IIb, which is huge news.
The Northeast ALS Consortium (NEALS) US Brainstorm Trial Statement ALS Clinical Trials
NEALS released a special statement regarding Brainstorm:
http://www.alsconsortium.org/news_us_brainstorm_statement_Feb2013.php
"February 26, 2013
We have had many inquires regarding the Brainstorm Stem Cell Therapeutics Clinical Trial. BrainStorm is currently conducting a Phase IIa dose-escalating trial at the Hadassah Medical Center in Israel. We are working with Brainstorm on a planned Phase II study in the US. We hope to begin the trial in the second half of 2013. We will continue to follow the progress of the study in Israel and will keep the NEALS website current on all new trials and start dates. Thank you for your interest."
I completely agree, lets hope we hear on FDA approval soon
The interview with Rasheda Ali was great, I feel like this stock has yet to get by the wave of hype/excitement and hopefully exposure like this will help.
Sorry... I meant Karina not Carina
erg...
That's a really good point Carina
I am hoping the share price would justify it if they completed their other two goals, might be a good question to pose during the next investor call.
Bonuses for $10 million, Nasdaq, FDA approval
Best part about the press release:
"In the event that after the date hereof but prior to the first anniversary of the Grant Date (and provided that Mr. Natanson is then actively employed by the Subsidiary): (i) the Company or Subsidiary shall have raised U.S.$10 million or more in one transaction, and (ii) the shares of Company shall have been admitted for trading on NASDAQ, and (iii) the Company or Subsidiary shall have been granted the approval of the FDA to conduct clinical trials in the United States, on the first anniversary of the Grant Date Mr. Natanson shall be granted an additional stock option for the purchase of an additional 2,000,000 shares of Company common stock upon the same terms as the Initial Grant."
Mr. Natason stands to make a lot more if he accomplishes these things in 2013...
Look like there was news out today too!
Management change, looks like they are really focusing on commercialization/selling end of things - pretty impressive how quickly they are moving.
http://biz.yahoo.com/e/130128/bcli8-k.html
Change in Directors or Principal Officers, Financial Statements
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Alon Natanson
On January 24, 2013, Brainstorm Cell Therapeutics Inc. (the "Company") appointed Alon Natanson as its Chief Executive Officer, effective February 1, 2013.
On January 24, 2013, BrainStorm Cell Therapeutics Ltd., a wholly owned subsidiary of the Company (the "Subsidiary"), and Alon Natanson entered into an employment agreement which sets forth the terms of employment. Pursuant to the agreement, Mr. Natanson will be paid a monthly salary of NIS53,000 (app. U.S.$14,200 based on current currency exchange rates). Mr. Natanson will also receive other benefits that are generally made available to the Company's employees, including pension and education fund benefits. The Company will provide Mr. Natanson with a Company car and cellular phone, and a gross-up payment for any taxes relating thereto. Mr. Natanson also received a grant of a stock option (the "Initial Grant") on January 24, 2013 (the "Grant Date") for the purchase of 4,000,000 shares of the Company's common stock (the "Shares"), which shall vest and become exercisable as to 33 1/3% of the Shares on the first anniversary of the Grant Date (the "Initial Vesting Date") and the remainder of the Shares shall vest and become exercisable in equal monthly installments on each of the 36 monthly anniversaries following the Initial Vesting Date. The exercise price for the Initial Grant will be $0.29 per share. In the event that after the date hereof but prior to the first anniversary of the Grant Date (and provided that Mr. Natanson is then actively employed by the Subsidiary): (i) the Company or Subsidiary shall have raised U.S.$10 million or more in one transaction, and (ii) the shares of Company shall have been admitted for trading on NASDAQ, and (iii) the Company or Subsidiary shall have been granted the approval of the FDA to conduct clinical trials in the United States, on the first anniversary of the Grant Date Mr. Natanson shall be granted an additional stock option for the purchase of an additional 2,000,000 shares of Company common stock upon the same terms as the Initial Grant.
Prior to joining the Company and the Subsidiary, Mr. Natanson led large as well as early-stage companies, in the fields of life science, high-tech, and retail. Prior positions include Director of Marketing and Finance at Teva Pharmaceuticals, Copaxone? division, where he was involved in commercialization of patented therapeutics for multiple sclerosis, establishing the division and planning and executing its international strategy and product launch. Since 2008 Mr. Natanson served as President and Chief Executive Officer of Procognia (TASE:
PRCG), a biotechnology company specializing in glycobiology and biopharmaceutical analytics.
Alon Natanson is 49 years old. There are no family relationships between Mr. Natanson and any member of the Board of Directors or other executive officer of the Company.
The above description of the employment agreement is qualified in its entirety by reference to the terms of the employment agreement, attached hereto as Exhibit 10.1 and incorporated herein by reference.
Adrian Harel
In connection with the appointment of Alon Natanson, Adrian Harel, Ph.D. will cease to serve as the Company's Chief Executive Officer effective February 1, 2013 but will continue to serve in an executive scientific role in the Company.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
The exhibit listed in the Exhibit Index below is filed with this report.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
January 28, 2013 Brainstorm Cell Therapeutics Inc.
Former Chief of Staff on Brainstorm's Advisory Board
Thought this was kind of interesting, did not notice it before:
http://www.brainstorm-cell.com/index.php/about-us/advisory-board
Andy Card
Mr. Card served as Chief of Staff to President George W. Bush from November 2000 to April 2006. Currently Mr. Card serves on the board of directors at Union Pacific Corporation (NYSE: UNP). He is also a senior counselor at the global public relations firm Fleischman-Hillard, serving on the international advisory board. Card is also a co-founder of the Lonsdale Group, a Managing Director of Lincoln Vale Canada International, on the global advisory board of Alexander Proudfoot, and on the advisory board of the United States Chamber of Commerce.
Prior to joining the White House, Mr. Card was Vice President-Government Relations for General Motors Corporation. From 1993 to 1998, he was President and Chief Executive Officer of the American Automobile Manufacturers Association. Mr. Card served as the 11th Secretary of Transportation under President George H.W. Bush from 1992 through 1993. He also served as a Deputy Assistant to the President and Director of Intergovernmental Affairs for President Ronald Reagan.
Audio From The Conference Call
Listed on their homepage now:
http://www.brainstorm-cell.com/index.php/news-a-events
Investor Presentation - Updated Jan 2013
I just noticed that the investor presentation on the brainstorm website has been updated as of January 2013 (was originally October 2012).
I noticed some differences, namely the recent news (deal with Octane etc..) there was also this, I have not done any DD on the people mentioned yet.
From Page 13:
Phase II study slated for 2013, pending FDA approval
Collaboration planned with world renowned ALS experts Profs. Robert Brown and Merit Cudkowitz
Concise DD - My findings Jan 2013
Hello everyone I'm new to this board. I typically do not post here, in fact I have been mostly just casually observing iHub since 2008. However, I stumbled upon BCLI a few weeks ago, and it seems a lot of people on the board are in the same position I was - namely, were compelled by this stock but knew nothing about it.
With that being said, I have done some research that I wish to share.
1. The Video
Anyone who has not seen this video regarding BCLI's ALS treatment NEEDS to watch it. It speaks for itself- Below is a link to the translated version.
Casual optimism: A time-line and a humble opinion
Let me first say that i rarely post here. By rarely i truly mean i have only posted on this board 3 times in regards to another stock. I avoid posting on I-hub, or any other board, because of the redundant spamming and negativity regarding this stock.
I have held shares of TNOG since 2005. I have witnessed incredible gains, of which i profited. I have been a part of incredible pitfalls, of which i have lost a great deal. All in all, the shares that now hold for the long term were technically free, and i would like to offer up as objective of an opinion as a i can possibly muster.
The OLD TNOG-
I was relatively close with the old management, in so far as being in email contact, as well as a couple phone calls. They were adept at creating a mountain out of a mole hill. I refer to Stanley wells (which were before the bastrop project). It was amazing, that the greatest run TNOG ever had was on news regarding a well that gurgled little more than a couple barrels a day of oil and a lot of salt water. I believe, at that point, TNOG had inklings of a real company, where people, Such as Pete Maupin, truly sought good in the company and really wanted it to work. I studied this company inside and out. I called everyone i possibly could (including midway pipeline, those who remember this drama). They were attempting to get off their feet, but never had any luck. A few downturns, a few dry wells, and TNOG would continuously post PR's that were full of "things to come" and hopes for good fortune. They wanted to keep the hype going. They ultimately faltered as there was not really anything to back it up. (this scenario is, i hate to use the term, verifiable; one can simply reviewing past TNOG press releases).
Allow me to digress, I even remember a time where now die hard "Bashers" were full supporters of this stock. I would assume a personal vendetta or some other motive for continuously posting against TNOG, it is amazing that 3 years later it still occurs... by the same people. I find it comical the life these people must have. Maybe this is some sick source of attention and wanted human drama that they lack. I will not delve any further into this.
The NEW TNOG-
I have maintained a "watchful eye" for a long time. As i am sure there are a number of you who are reading posts but never actually write any. I dont think anyone can blame me for having a sort of natural reticence for believing the first string of PR's, which appeared out of no where after a long silence.
There are number of differences in the way this company has been handled since new management has been hired. Most notably, the scope. Let me explain. Where as TNOG used to concern themselves with one or two wells, they are now concerned with fields of wells (PA in excess of 60). This caught my attention straight off. This is what a corporation should be focusing on. Call it being naive, but in retrospect i should have noticed the narrow focus of the OLD management right off the bat... live and learn.
Secondly, the candid and very open nature of Brandon Toth is very different from the seemingly gagged old management. I have also received a few very pleasant phone calls from a number of different people working for TNOG. This is a complete change from the shady, and almost slimy way that "Novak Capital" used to promote TNOG (again, for those who remember these people, Clayton Smith was his name if my memory serves me correctly).
I have to say that my interest in this stock has peaked again. I am enjoying the influx of news. I am loving the positive attitude from both investors and company. I have not witnessed this since TNOG's first real run all the way up to .05. My motivation for posting is because of this. If anything, i have enjoyed the drama which this company has waded through, and truly if this is the start of something great i would love to be here on the ground floor. The fun in these stocks is doing research, is picking up the phone, is questioning things. That's why the burden of proof, at least while on the pinksheets, is in our hands.
My faith, at this point, is not fully restored. This is not because i think TNOG is not truly attempting at becoming a fully fledged oil company. It is simply because this is still a pinksheet stock. I have emailed management a number of times explaining to them the urgency of filing for full reporting status. That is the last obstacle in the way. I can understand the burden this causes when you take of a company from practically fraudulent hands. That will be the only true way of clearing the air. I believe most investors (including myself) are waiting to invest more, invest initially, or re-invest until TNOG lists becomes fully reporting. Anyone with the remotest of conservative attitude towards investing would have to agree.
Most investors realize the gamble. I think of the Pinksheets like the wildwest. You can be on top of the world one second and shot dead in a gutter the next. There are only a few stocks that ever climb out. The pinksheets are a bastion for shell companies and lies; anyone can say anything. I would find it most refreshing to find some honesty, and goodness down here, because this is where i like to play. I, like most of you, are quietly sifting through the soot, looking for something worth taking home.
I hope that if we all work together with TNOG, do our due diligence, we can show that we have found something here worth investing in, or we can uncover lies and deceit (which, up to this point, i have been unable to do).
At this point i remain casually optimistic. I am always hoping for the best, but i am prepared to face the music. I appreciate all the good posts by everyone. Hopefully, i will find something worth saying more than just once every few years.
JC-
All in my own opinion and all that jazz.